Acro Biomedical is a dormant nutritional products company based in Fishers, Indiana. Its core product is cordyceps, a fungus used in traditional Chinese medicine, which Acro Biomedical historically purchased from suppliers in Taiwan and resold in bulk to distributors in Taiwan and Hong Kong. Customers typically used the cordyceps as an ingredient in their own products. Acro Biomedical does not manufacture anything — its business model was purely buy-and-resell, with all sales historically made by the CEO personally. The company has generated no revenue since late 2022, holds no inventory, and has nominal cash. Its sole employee — who served as both CEO and CFO — resigned in August 2025. Operations are effectively dormant, and the company has been funded by advances from a minority stockholder. Acro Biomedical acknowledges it cannot guarantee it will recommence operations.